1. Antinociceptive and wound healing effects of a commercial formulation of lidocaine, bupivacaine, adrenaline and cetrimide applied topically to superficial skin wounds in horses.
- Author
-
Pratt, Shaun, Sole‐Guitart, Albert, de Klerk, Karla, Evans, Elizabeth, Hume, Jane, Palmieri, Chiara, Rainger, Joanne, and Goodwin, Wendy
- Abstract
Background: Post‐traumatic distal limb wounds cause discomfort and heal gradually by second intention. The topical application of Tri‐Solfen (lidocaine hydrochloride, bupivacaine hydrochloride, adrenaline acid tartrate and cetrimide [LBAC]) produces effective postsurgical cutaneous analgesia in lambs, calves and piglets; however, its effect on wounds in horses is unknown. Methods: The antinociceptive effect, measured by mechanical threshold (MT), and the wound healing impacts of LBAC compared with saline were investigated on surgically created 20 × 20 mm distal limb wounds in 10 horses. Treatment was applied once daily for 7 days following wounding on day 0. Mechanical thresholds were measured after treatment on days 1, 2 and 3. Healing was observed for 25 days. Results: The topical application of LBAC immediately following wounding and its reapplication 24 hours later increased the average MT on the first post‐traumatic day by 3 Newtons. However, no antinociceptive benefit was observed on days 2 or 3. Treatment with LBAC did not adversely affect wound healing when compared with saline. Limitations: Methodological differences preclude absolute MT comparisons between studies. The experimental design did not include a model of contaminated or naturally occurring wounds. Conclusion: LBAC may provide an early antinociceptive benefit when applied to uncontaminated surgically created wounds without compromising healing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF